Status:
UNKNOWN
Procalcitonin in Diagnosis of Sepsis in Critically Ill Patient
Lead Sponsor:
Assiut University
Conditions:
Sepsis, Severe
Eligibility:
All Genders
18-70 years
Brief Summary
correlation between procalcitonin levels and the severity of sepsis and it's possibility to be used as a prognostic marker in patients with sepsis and severe sepsis
Detailed Description
Sepsis is the systemic response to infection by microbial organisms and is considered the leading cause of mortality in patients admitted to intensive care units (ICUs). Audits of ICU worldwide showed...
Eligibility Criteria
Inclusion
- adult patients \>18 years who were admitted to intensive care unit of Assiut University Hospital with symptoms of systemic infection and with a clinical suspicion of sepsis as guided by the ICU physician
Exclusion
- Patients above 70 years of age
- Patients who received antibiotic therapy within three days prior to sample collection
Key Trial Info
Start Date :
November 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2021
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04105400
Start Date
November 1 2019
End Date
December 1 2021
Last Update
September 30 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.